As Lipitor Lawsuits Progress, Bernstein Liebhard LLP Notes Publication of New Study Linking Statins to Cataract Development

Share Article

This study’s publication comes as hundreds of Lipitor lawsuit plaintiffs seek compensation for Type 2 diabetes they allegedly developed due to their use of the cholesterol-lowering statin.

Free Case Review
This research just serves to remind that statins may be associated with some serious health consequences, especially in light of the litigation involving Lipitor and diabetes that is currently underway in federal court.

As hundreds of Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that allege the medication caused Type 2 diabetes move through federal court, Bernstein Liebhard LLP notes the publication of a new study linking statins to the development of another serious side effect. According to a report from HealthDay News, Canadian researchers have revealed that the use of Lipitor and other statins may increase the risk for cataracts, a vision disorder that causes the lens of the eye to become cloudy.*

The study, which appears in the December issue of the Canadian Journal of Cardiology, looked at more than 207,000 adults with cataracts and more than 1.1 million without them. The research team found that patients who had taken statins for a year could face as much as a 27% increased risk for cataracts compared to those who did not use the medications. According to HealthDay News, the lead author of the study said that additional clinical trials are necessary to determine if, in fact, statins can cause cataracts.

"This research just serves to remind that statins may be associated with some serious health consequences, especially in light of the litigation involving Lipitor and diabetes that is currently underway in federal court,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who may have been harmed by Lipitor.

Lipitor Diabetes Litigation
Court documents indicate that more than 1,400 Lipitor lawsuits have been filed in a federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, all of which accuse Pfizer Inc. of concealing information about the drug’s association with diabetes in order to protect sales of the medication. According to court documents, plaintiffs further allege that they would not have used Lipitor, or would have been more closely monitored for diabetes, had Pfizer’s warnings been sufficient. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

The litigation involving Lipitor and diabetes has been growing since February 2012, when the U.S. Food & Drug Administration (FDA) announced that the labels for Lipitor and other statins would be updated to include new information about their potential association with Type 2 diabetes. The FDA announcement followed the publication of a study in JAMA: Internal Medicine the previous month which suggested that post-menopausal women treated with statins faced an increased risk of developing new-onset Type 2 diabetes. **

Type 2 diabetes patients who allegedly developed the disease due to their use of Lipitor may be able to pursue their own case against Pfizer. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*consumer.healthday.com/eye-care-information-13/cataracts-health-news-116/could-your-daily-statin-raise-your-risk-for-cataracts-694356.html, HealthDay News, December 5, 2014
**archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.lipitorlawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website